Riskpilot← Back to searchSign inGet full accessGREFSEN FYSIOTERAPI AS
ASActiveOrg 985331766Grefsenveien 61, 0487 OsloRental and operating of own or leased real estate · NACE 6820Est. 20030 employees
Revenue 2025
NOK 1,2M
+1% vs 2024
EBITDA margin
0.8%
+115% vs 2024
Equity ratio
48.4%
Financial strength
Net profit 2025
NOK -23
+100% vs 2024
| Revenue | NOK 1,2M | +1% |
| EBITDA | NOK 10K | +115% |
| Net profit | NOK -23 | +100% |
| Total assets | NOK 213K | +23% |
| Equity | NOK 103K | +0% |
| Employees | 0 | — |
Legal name
GREFSEN FYSIOTERAPI AS
Org number
985331766
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
31. januar 2003
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Forestå organisering og videreutleie av lokaler til fysikalsk behandling og andre helsetjenester, samt annen virksomhet som naturlig måtte stå i forbindelse med dette.
Address
Grefsenveien 61, 0487 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 186 | 1 163 | 1 160 | 1 199 | 1 215 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 38 | −9 | −3 | −62 | 10 |
| Depreciation & amort. | −0 | −0 | −1 | −12 | −12 |
| EBIT | 38 | −9 | −4 | −74 | −2 |
| Net financials | 2 | 2 | 0 | 2 | 2 |
| Profit before tax | 40 | −8 | −4 | −72 | −0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 40 | −8 | −4 | −72 | −0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 229 | 204 | 217 | 174 | 213 |
| Equity | 187 | 179 | 175 | 103 | 103 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 42 | 25 | 41 | 70 | 110 |
| Total debt | 42 | 25 | 41 | 70 | 110 |
EBITDA margin
0.8%
This company
15.8%
Market median
-95% vs market
20212025
Equity ratio
48.4%
This company
38.2%
Market median
+27% vs market
20212025
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
-0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
5.69×
This company
1.12×
Market median
+408% vs market
20212025
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2014 | |
| Board of Directors | 2014 | |
| Board of Directors | 2014 | |
| Chairman | 2014 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GREFSEN FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christine Saxegaard | Board of Directors | 0 companies |
| Jan Gunnar Lien | Board of Directors | 0 companies |
| Heidi Ødegaard Bjertnæs | Board of Directors | 0 companies |
| Bernt Fiskeseth | Chairman | 0 companies |